Search research articles
Contact Us
Filters
Showing results (61-70 of 70) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 70 results.
Clinical Journal of the American Society of Nephrology : CJASN
|
April 23, 2016
Age and Outcomes Associated with BP in Patients with Incident CKD
Csaba P Kovesdy, Ahmed Alrifai, Elvira O Gosmanova, et al.
The American Journal of Medicine
|
April 25, 2020
Longer Predialysis ACEi/ARB Utilization Is Associated With Reduced Postdialysis Mortality
Elvira O Gosmanova, Miklos Z Molnar, Adnan Naseer, et al.
Kidney International Reports
|
August 1, 2017
<i>APOL1</i> renal-risk variants do not associate with incident cardiovascular disease or mortality in the Systolic Blood Pressure Intervention Trial
Barry I Freedman, Michael V Rocco, Jeffrey T Bates, et al.
European Heart Journal
|
July 2, 2019
Markers of kidney tubule function and risk of cardiovascular disease events and mortality in the SPRINT trial
Pranav S Garimella, Alexandra K Lee, Walter T Ambrosius, et al.
American Journal of Nephrology
|
August 12, 2016
Chronic Kidney Disease Classification in Systolic Blood Pressure Intervention Trial: Comparison Using Modification of Diet in Renal Disease and CKD-Epidemiology Collaboration Definitions
Michael V Rocco, Arlene Chapman, Glenn M Chertow, et al.
Journal of the American Society of Hypertension : JASH
|
September 1, 2015
Baseline characteristics of African Americans in the Systolic Blood Pressure Intervention Trial
Carolyn H Still, Timothy E Craven, Barry I Freedman, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
November 15, 2018
PTH, FGF23, and Intensive Blood Pressure Lowering in Chronic Kidney Disease Participants in SPRINT
Charles Ginsberg, Timothy E Craven, Michel B Chonchol, et al.
American Journal of Hypertension
|
October 7, 2017
Clinical Outcomes by Race and Ethnicity in the Systolic Blood Pressure Intervention Trial (SPRINT): A Randomized Clinical Trial
Carolyn H Still, Carlos J Rodriguez, Jackson T Wright, et al.
Kidney International
|
July 3, 2019
The SPRINT trial suggests that markers of tubule cell function in the urine associate with risk of subsequent acute kidney injury while injury markers elevate after the injury
Alexander L Bullen, Ronit Katz, Alexandra K Lee, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
November 23, 2017
Effects of Intensive Blood Pressure Treatment on Acute Kidney Injury Events in the Systolic Blood Pressure Intervention Trial (SPRINT)
Michael V Rocco, Kaycee M Sink, Laura C Lovato, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 70) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 70 results.
Clinical Journal of the American Society of Nephrology : CJASN
|
April 23, 2016
Age and Outcomes Associated with BP in Patients with Incident CKD
Csaba P Kovesdy, Ahmed Alrifai, Elvira O Gosmanova, et al.
The American Journal of Medicine
|
April 25, 2020
Longer Predialysis ACEi/ARB Utilization Is Associated With Reduced Postdialysis Mortality
Elvira O Gosmanova, Miklos Z Molnar, Adnan Naseer, et al.
Kidney International Reports
|
August 1, 2017
<i>APOL1</i> renal-risk variants do not associate with incident cardiovascular disease or mortality in the Systolic Blood Pressure Intervention Trial
Barry I Freedman, Michael V Rocco, Jeffrey T Bates, et al.
European Heart Journal
|
July 2, 2019
Markers of kidney tubule function and risk of cardiovascular disease events and mortality in the SPRINT trial
Pranav S Garimella, Alexandra K Lee, Walter T Ambrosius, et al.
American Journal of Nephrology
|
August 12, 2016
Chronic Kidney Disease Classification in Systolic Blood Pressure Intervention Trial: Comparison Using Modification of Diet in Renal Disease and CKD-Epidemiology Collaboration Definitions
Michael V Rocco, Arlene Chapman, Glenn M Chertow, et al.
Journal of the American Society of Hypertension : JASH
|
September 1, 2015
Baseline characteristics of African Americans in the Systolic Blood Pressure Intervention Trial
Carolyn H Still, Timothy E Craven, Barry I Freedman, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
November 15, 2018
PTH, FGF23, and Intensive Blood Pressure Lowering in Chronic Kidney Disease Participants in SPRINT
Charles Ginsberg, Timothy E Craven, Michel B Chonchol, et al.
American Journal of Hypertension
|
October 7, 2017
Clinical Outcomes by Race and Ethnicity in the Systolic Blood Pressure Intervention Trial (SPRINT): A Randomized Clinical Trial
Carolyn H Still, Carlos J Rodriguez, Jackson T Wright, et al.
Kidney International
|
July 3, 2019
The SPRINT trial suggests that markers of tubule cell function in the urine associate with risk of subsequent acute kidney injury while injury markers elevate after the injury
Alexander L Bullen, Ronit Katz, Alexandra K Lee, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
November 23, 2017
Effects of Intensive Blood Pressure Treatment on Acute Kidney Injury Events in the Systolic Blood Pressure Intervention Trial (SPRINT)
Michael V Rocco, Kaycee M Sink, Laura C Lovato, et al.
Page
of 7